Drugs for Helicobacter Pylori Infection (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 136)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Azithromycin |
Approved |
Phase 4 |
|
83905-01-5 |
447043 |
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
Azadose
AZASITE
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
AZITHROMYCIN
AZITHROMYCIN ANHYDROUS
Azithromycin dihydrate
AZITHROMYCIN HYDRATE
Azithromycin monohydrate
Azithromycin pfizer brand
Azithromycine
Azithromycinum
Azitrocin
Azitromicina
Azitromin
AZYTER
Azythromycin
Bayer brand OF azithromycin dihydrate
CLAMELLE
CP 62993
|
CP-62,993
CP-62993
Dihydrate, azithromycin
Funk brand OF azithromycin dihydrate
Goxal
Hemomycin
Lesvi brand OF azithromycin dihydrate
Mack brand OF azithromycin dihydrate
Monohydrate, azithromycin
Pfizer brand OF azithromycin
Pfizer brand OF azithromycin dihydrate
Pharmacia brand OF azithromycin dihydrate
Sumamed
SUNAMED
Toraseptol
Ultreon
Vinzam
Vita brand OF azithromycin dihydrate
XZ 405
XZ 450
XZ-450
Zentavion
Zithromax
Zitromax
Zmax
|
|
2 |
|
Roxithromycin |
Approved, Investigational, Withdrawn |
Phase 4 |
|
80214-83-1 |
6915744 |
Synonyms:
(9E)-ERYTHROMYCIN 9-(O-((2-METHOXYETHOXY)METHYL)OXIME)
1a Brand OF roxithromycin
9-[O-(2-Methoxyethoxymethyl)-oxime] OF erythromycin
Alpharma brand OF roxithromycin
Aventis brand OF roxithromycin
Basics brand OF roxithromycin
Betapharm brand OF roxithromycin
Biaxsig
Claramid
CT-Arzneimittel brand OF roxithromycin
Faes brand OF roxithromycin
Grünenthal brand OF roxithromycin
Hexal brand OF roxithromycin
Hoechst brand OF roxithromycin
Infectopharm brand OF roxithromycin
Infectoroxit
Juta brand OF roxithromycin
Knoll brand OF roxithromycin
Lichtenstein brand OF roxithromycin
Macrosil
Medeva brand OF roxithromycin
Merck dura brand OF roxithromycin
MIP brand OF roxithromycin
MTW Brand OF roxithromycin
MTW-Roxithromycin
Pfizer brand OF roxithromycin
Rotesan
Rotramin
|
Roxi 1a pharma
Roxi basics
Roxi tad
Roxi von CT
Roxibeta
Roxidura
Roxigamma
Roxigrün
Roxihexal
Roxi-paed 1a pharma
Roxi-puren
Roxi-Q
Roxi-saar
Roxithro-lich
ROXITHROMYCIN
Roxithromycin hexal brand
ROXITHROMYCINE
ROXITHROMYCINUM
ROXITROMICINA
Roxi-wolff
RU-28965
RU-965
Rulid
Rulide
Sigma brand OF roxithromycin
TAD brand OF roxithromycin
Wolff brand OF roxithromycin
Wörwag brand OF roxithromycin
|
|
3 |
|
Coal tar |
Approved |
Phase 4 |
|
8007-45-2 |
|
Synonyms:
|
4 |
|
Loperamide |
Approved |
Phase 4 |
|
53179-11-6 |
3955 |
Synonyms:
Apo-loperamide
Diamide
FORTASEC
Fortasec®|Imodium®|R-18553
Hydrochloride, loperamide
Imodium
Imodium a-D
Imodium a-D caplets
Kaopectate II
Loperacap
Loperamid
Loperamida
|
Loperamide
Lopéramide
Loperamide hydrochloride
Loperamide monohydrochloride
Loperamidum
Maalox anti-diarrheal
Monohydrochloride, loperamide
Nu-loperamide
PMS-Loperamide
R-18553
Rho-loperamide
|
|
5 |
|
Bismuth subsalicylate |
Approved, Vet_approved |
Phase 4 |
|
14882-18-9 |
53629521 16682734 |
Synonyms:
2-Hydroxy-benzo[1,3,2]dioxabismin-4-one
Basic bismuth salicylate
Basic bismuth salicylic acid
BISMUKOTE
Bismuth
Bismuth oxide salicylate
Bismuth oxide salicylic acid
Bismuth oxysalicylate
Bismuth oxysalicylic acid
BISMUTH SUBSALICYLATE
Bismuth subsalicylic acid
Bismuth(III) subsalicylate
|
Bismuthi subsalicylas
Bismutum subsalicylicum
CORRECTIVE SUSPENSION
GASTRO-COTE
Helidac
Kaopectate
Pepto-bismol
Pink bismuth
Subsalicylate bismuth
Trigastronol
Wismutsubsalicylat
|
|
6 |
|
Titanium dioxide |
Approved |
Phase 4 |
|
13463-67-7 |
|
Synonyms:
dióxido de titanio
óxido de titanio(4)
|
|
|
7 |
|
Trimebutine |
Approved |
Phase 4 |
|
39133-31-8 |
5573 |
Synonyms:
2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoic acid
2-DIMETHYLAMINO-2-PHENYLBUTYL 3,4,5-TRIMETHOXYBENZOAT
Debridat
Maleate salt, trimebutine
Maleate, trimebutine
Modulon
Polibutin
Salt, trimebutine maleate
|
Transacalm
Trimebutina
TRIMEBUTINE
TRIMÉBUTINE
Trimebutine maleate
Trimebutine maleate salt
TRIMEBUTINO
|
|
8 |
|
Rifabutin |
Approved, Investigational |
Phase 4 |
|
72559-06-9 |
46783538 6323490 |
Synonyms:
1,4-DIHYDRO-1-DEOXY-1',4-DIDEHYDRO-5'-(2-METHYLPROPYL)-1-OXORIFAMYCIN XIV
4-DEOXO-3,4-(2-SPIRO(N-ISOBUTYL-4-PIPERIDYL)-2,5-DIHYDRO-1H-IMIDAZO)-RIFAMYCIN S
4-N-ISOBUTYLSPIROPIPERIDYLRIFAMYCIN S
ANSAMICIN
ANSAMYCIN
LM 427
LM-427
|
MYCOBUTIN
MYCOBUTIN (TN)
RIFABUTIN
RIFABUTINA
RIFABUTINE
RIFABUTINUM
|
|
9 |
|
Doxycycline |
Approved, Investigational, Vet_approved |
Phase 4 |
|
564-25-0 |
54671203 |
Synonyms:
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
5-Hydroxy-a-6-deoxytetracycline
5-Hydroxy-alpha-6-deoxytetracycline
5-Hydroxy-α-6-deoxytetracycline
6a-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
6alpha-Deoxy-5-oxytetracycline
6Α-deoxy-5-oxytetracycline
Anhydrous doxycycline
BMY-28689|Monodox®|Vibramycin®
Doxcycline anhydrous
Doxiciclina
DOXY
Doxychel
Doxycyclin
Doxycycline
|
Doxycycline (anhydrous)
DOXYCYCLINE ANHYDROUS
DOXYCYCLINE HCL
Doxycycline hyclate
Doxycycline hydrate
Doxycycline hydric acid
Doxycycline monohydrate
Doxycycline monohydric acid
Doxycyclinum
Doxytetracycline
GS-3065
Jenacyclin
Monodox
Oracea
Supracyclin
Vibramycin
|
|
10 |
|
Minocycline |
Approved, Investigational |
Phase 4 |
|
10118-90-8, 13614-98-7 |
54675783 5281021 |
Synonyms:
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
7-Dimethylamino-6-demethyl-6-deoxytetracycline
ACNAMINO
AKNEMIN
AKNEMIN 50
Alti-Minocycline
Apo-Minocycline
ARESTIN
BLEMIX 100
BLEMIX 50
CYCLOMIN
DENTOMYCIN
DYNACIN
Gen-Minocycline
KLINOMYCIN
MINO
Minociclina
Minociclina [INN-Spanish]
Minociclinum
MINOCIN
|
MINOCIN 50
MINOCIN MR
MINOCYCLIN
MINOCYCLINE
MINOCYCLINE HCL
MINOCYCLINE HYDROCHLORIDE
MINOCYCLINUM
Minocyclinum [INN-Latin]
Minocyn
MINOGAL
MINOLIRA
Minomycin
Novo-Minocycline
NSC-141993
SEBOMIN
SEBREN MR
SOLODYN
VECTRIN
XIMINO
|
|
11 |
|
Pantoprazole |
Approved |
Phase 4 |
|
102625-70-7, 138786-67-1 |
4679 |
Synonyms:
6-(DIFLUOROMETHOXY)-2-{[(3,4-DIMETHOXYPYRIDIN-2-YL)METHANE]SULFINYL}-1H-1,3-BENZODIAZOLE
Astropan
BY-1023
PAN023
Pantoloc
PANTOLOC CONTROL
Pantopan
Pantoprazol
Pantoprazol [INN-Spanish]
PANTOPRAZOLE
Pantoprazole Na
Pantoprazole sodium
Pantoprazole sodium hydrate
Pantoprazolum
Pantoprazolum [INN-Latin]
|
Pantoprozole
Pantor
Pantozol
PROTIUM
PROTIUM I.V.
Protonix
Protonix i.v.
Protonix IV
SK And F 96022
SK And F96022
SK And F-96022
SK&F-96022
SK-96022
SKF-96022
|
|
12 |
|
Potassium citrate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
866-84-2 |
|
Synonyms:
Potassium citrate anhydrous
Potassium citric acid
|
Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
Tripotassium citrate
|
|
13 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
14 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 4 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Β-HYDROXYAMPHETAMINE
|
|
15 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
16 |
|
Rabeprazole |
Approved, Investigational |
Phase 4 |
|
117976-89-3, 117976-90-6 |
5029 |
Synonyms:
1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, sodium salt
2-((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
Aciphex
ACIPHEX SPRINKLE
Clofezone
Dexrabeprazole
E3810
E-3810
E-3810 (PPI)
E-3810 SODIUM
Eraloc
Habeprazole
Irsogladine Maleate
|
LY307640
LY-307640
LY307640 SODIUM
LY-307640 SODIUM
Pariet
Pariets
RABEPRAZOLE
Rabeprazole sodium
RABEPRAZOLE SODIUM SALT
Rebeprazole sodium
Sodium rabeprazole
Sodium, rabeprazole
|
|
17 |
|
Levofloxacin |
Approved, Investigational |
Phase 4 |
|
100986-85-4 |
149096 |
Synonyms:
(-)-Ofloxacin
(2S)-7-FLUORO-2-METHYL-6-(4-METHYLPIPERAZIN-1-YL)-10-OXO-4-OXA-1-AZATRICYCLO[7.3.1.0^{5,13}]TRIDECA-5(13),6,8,11-TETRAENE-11-CARBOXYLIC ACID
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
Anhydrous, levofloxacin
Cravit
DR-3355
EVOXIL
FLOXACIN
Floxin
IQUIX
Levaquin
|
LEVOFLOXACIN
Levofloxacin anhydrous
LEVOFLOXACIN HEMIHYDRATE
Levofloxacin hydrate
Levofloxacine
Levofloxacino
Levofloxacinum
L-Ofloxacin
Ofloxacin
Ofloxacin S-(-)-form
OFLOXACIN S-(-)-FORM HEMIHYDRATE
Ofloxacin, (S)-isomer
OFTAQUIX
QUINSAIR
Quixin
RWJ-25213
TAVANIC
|
|
18 |
|
Ofloxacin |
Approved |
Phase 4 |
|
82419-36-1 |
4583 |
Synonyms:
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
Akilen
Baccidal
Bactocin
Danoflox
DL-8280
Effexin
EXOCIN
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
FLOXIN OTIC
Floxstat
Fugacin
Hoe 280
Hoe-280
Inoflox
J01MA01
Kinflocin
Kinoxacin
Liflox
Loxinter
Marfloxacin
Medofloxine
Mergexin
Novecin
Nufafloqo
Obide
Occidal
OCUFLOX
Ofcin
Oflin
Oflocee
Oflocet
|
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
OFLOXACIN
Ofloxacin hydrochloride
Ofloxacine
Ofloxacino
Ofloxacinum
Ofloxin
OFLX
Ofus
Onexacin
Operan
Orocin
Otonil
Pharflox
Praxin
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Sinflo
Tabrin
Taravid
Tariflox
Tarivid
TARIVID 400
TARIVID I.V.
Telbit
Tructum
Uro Tarivid
Viotisone
VISIREN
Zanocin
|
|
19 |
|
Clavulanic acid |
Approved, Vet_approved |
Phase 4 |
|
58001-44-8 |
5280980 |
Synonyms:
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylate
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
Acide clavulanique
Acido clavulanico
ácido clavulánico
Acidum clavulanicum
Antibiotic MM 14151
BRL-14151
Clavulanate
Clavulanate potassium
Clavulanate, potassium
Clavulanate, sodium
|
Clavulanic acid
Clavulanic acid, monopotassium salt
Clavulanic acid, monosodium salt
Clavulansaeure
Clavulansäure
Clavulonate
Clavulonic acid
Clavulox
CVA
MM 14151
Potassium clavulanate
Potassium, clavulanate
RX-10100
Sodium clavulanate
|
|
20 |
|
Ubidecarenone |
Approved, Investigational, Nutraceutical |
Phase 4 |
|
303-98-0 |
5281915 |
Synonyms:
(all-e)-2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
(all-e)-2,3-Dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-cyclohexadiene-1,4-dione
2-((all-e)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
2,3-Dimethoxy-5-methyl-6-decaprenylbenzoquinone
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-cyclohexadiene-1,4-dione
2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone
4-Ethyl-5-fluoropyrimidine
Adelir
all-trans-Ubiquinone
API 31510
API-31510
Aqua Q 10l10
Aqua Q10
Bio-quinon
Bio-quinone Q10
Coenzyme Q10
Coenzyme Q-10
CO-Enzyme Q10
CoQ
CoQ 10
CoQ10
Ensorb
Kaneka Q10
|
Kudesan
Li-Q-sorb
Liquid-Q
Neuquinon
Neuquinone
NSC-140665
NSC-140865
PureSorb Q 40
Q
Q 10AA
Q 199
Q10
Q-Gel
Q-Gel 100
Q-Ter
Ubidecarenone
UBIDECARENONE FOR SYSTEM SUITABILITY
Ubiquinone
Ubiquinone 10
Ubiquinone 50
Ubiquinone Q10
UBIQUINONE-10
Unbiquinone
Unispheres Q 10
|
|
21 |
|
Glycine |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
56-40-6 |
750 |
Synonyms:
[<sup>14</sup>C]-glycine
2-Aminoacetate
2-Aminoacetic acid
Acid, aminoacetic
Aciport
Aminoacetate
Amino-acetate
Amino-acetic acid
AMINOACETIC ACID
AMINOESSIGSAEURE
AMINOESSIGSÄURE
Aminoethanoate
AMINOETHANOIC ACID
Calcium salt glycine
Cobalt salt glycine
Copper salt glycine
FEMA NO. 3287
G
Glicina
Glicoamin
GLY
GLYCIN
GLYCINE
Glycine carbonate (1:1), monosodium salt
Glycine carbonate (2:1), monolithium salt
Glycine carbonate (2:1), monopotassium salt
Glycine carbonate (2:1), monosodium salt
Glycine hydrochloride
Glycine hydrochloride (2:1)
Glycine phosphate
|
Glycine phosphate (1:1)
Glycine sulfate (3:1)
Glycine, calcium salt
Glycine, calcium salt (2:1)
Glycine, cobalt salt
Glycine, copper salt
Glycine, monoammonium salt
Glycine, monopotasssium salt
Glycine, monosodium salt
Glycine, sodium hydrogen carbonate
GLYCOCOLL
GLYCOLIXIR
Glycosthene
GLYKOKOLL
GLYZIN
Gyn-hydralin
H2N-CH2-COOH
HGLY
Hydrochloride, glycine
LEIMZUCKER
Monoammonium salt glycine
Monopotasssium salt glycine
Monosodium salt glycine
NSC-25936
Padil
Phosphate, glycine
Salt glycine, monoammonium
Salt glycine, monosodium
جلايسين
|
|
22 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
23 |
|
Sulforaphane |
Investigational |
Phase 4 |
|
4478-93-7, 142825-10-3 |
5350 |
Synonyms:
(-)-sulforaphane
(R)-sulforaphane
(R)-Sulphoraphane
1-Isothiocyanato-4-methylsulphinylbutane
4-(METHYLSULFINYL)BUTYL ISOTHIOCYANATE
4-methylsulfinylbutyl isothiocyanate
|
4-Methylsulphinylbutyl glucosinolate
Methylsulfoxybutylisothiocyanate
Sulforafan
SULFORAPHANE
Sulphorafan
Sulphoraphane
|
|
24 |
|
Lactoferrin |
Investigational |
Phase 4 |
|
151186-19-5 |
|
Synonyms:
|
25 |
|
Meclocycline |
Investigational |
Phase 4 |
|
2013-58-3 |
54684337 |
Synonyms:
7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacene carboxamide
GS-2989
Meclan
Meclociclina
MECLOCYCLINE
|
Meclocycline monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,12aalpha))-isomer
Meclocycline sulfosalicylate
Meclocyclinum
Meclosorb
Samil
|
|
26 |
|
Fluoroquinolones |
|
Phase 4 |
|
|
|
27 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
28 |
|
Antiviral Agents |
|
Phase 4 |
|
|
|
29 |
|
Antidotes |
|
Phase 4 |
|
|
|
30 |
|
Antioxidants |
|
Phase 4 |
|
|
|
31 |
|
Ubiquinone |
|
Phase 4 |
|
|
|
32 |
|
Bile Acids and Salts |
|
Phase 4 |
|
|
|
33 |
|
Antidiarrheals |
|
Phase 4 |
|
|
|
34 |
|
Parasympatholytics |
|
Phase 4 |
|
|
|
35 |
|
Antimalarials |
|
Phase 4 |
|
|
|
36 |
|
Penicillins |
|
Phase 4 |
|
|
|
37 |
|
Acidophilus |
|
Phase 4 |
|
|
|
38 |
|
Bifidobacterium |
|
Phase 4 |
|
|
|
39 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
40 |
|
Expectorants |
|
Phase 4 |
|
|
|
41 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
42 |
|
Citrate |
|
Phase 4 |
|
|
|
43 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 4 |
|
|
|
44 |
|
Protective Agents |
|
Phase 4 |
|
|
|
45 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
46 |
|
Bee Products |
|
Phase 4 |
|
|
|
47 |
|
Propolis |
|
Phase 4 |
|
|
|
48 |
|
Amoxicillin-Potassium Clavulanate Combination |
|
Phase 4 |
|
|
|
49 |
|
beta-Lactamase Inhibitors |
|
Phase 4 |
|
|
|
50 |
|
Moxifloxacin |
Approved, Investigational |
Phase 3 |
|
186826-86-8, 354812-41-2, 151096-09-2 |
152946 |
Synonyms:
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Actira
Avalox
Avelox
AVELOX I.V.
BAY 12-8039
|
Izilox
MOXIFLOXACIN
Moxifloxacin HCl
Moxifloxacin hydrochloride
Moxifloxacino
Octegra
Proflox
VIGAMOX
|
|
Interventional clinical trials:
(show top 50)
(show all 382)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Comparison of the Efficacy of Clarithromycin-based Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial |
Unknown status |
NCT01906879 |
Phase 4 |
triple, quadruple, non-bismuth quadruple therapy |
2 |
High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection |
Unknown status |
NCT02553083 |
Phase 4 |
Nexium 40 mg;amoxicillin 1.5 gr;doxycycline 200 mg;Nexium 20 mg;clarythromicin 500 mg;amoxicillin 1gr |
3 |
Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy of Treatment of Helicobacter Pylori Infection in Korea |
Unknown status |
NCT02108184 |
Phase 4 |
Sequential therapy 10 days;Sequential therapy 14 days;Concomitant therapy 10 days;Concomitant therapy 14 days |
4 |
Analysis of the Impact of Helicobacter Pylori Infection and Eradication on Salivary Microbiome in Adults by 16S Pyrosequencing |
Unknown status |
NCT03730766 |
Phase 4 |
Esomeprazole;Amoxicillin;Bismuth Potassium Citrate |
5 |
Comparison of the Efficacy of Triple Therapy With or Without Acetylcysteine in the First Line of Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial |
Unknown status |
NCT02249546 |
Phase 4 |
N-acetylcysteine + PPI-amoxicillin-clarithromycin;PPI-amoxicillin-clarithromycin |
6 |
Comparison of the Efficacy of 14-day Sequential Therapy and 10-day Bismuth Quadruple Therapy in the Second Line Therapy for Helicobacter Pylori Infection: A Multi-center Randomized Trial |
Unknown status |
NCT03208426 |
Phase 4 |
Esomeprazole (S14);Esomeprazole (BQ10);Amoxicillin (ST14);Clarithromycin (ST14);Metronidazole (ST14);dibismuth trioxide 120mg (BQ10);Metronidazole (BQ10);tetracycline (BQ10) |
7 |
14-Day Antimicrobial Susceptibility Testing Guided Therapy Versus Personal Medication History Guided Therapy as a Rescue Treatment of Helicobacter Pylori Infection-A Randomized Controlled Trail |
Unknown status |
NCT03565484 |
Phase 4 |
susceptibility guided therapy;personal medication history guided therapy;salvage treatment for failed eradication |
8 |
Comparison of the Efficacy of Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy for 10 Days in the First Line Therapy for Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial |
Unknown status |
NCT01607918 |
Phase 4 |
D1-D5: (lansoprazole + amoxicillin ) D6-D10: (lansoprazole+clarithromycin +metronidazole);D1-D14: (lansoprazole + clarithromycin + amoxicillin) |
9 |
10-Day Antimicrobial Susceptibility Testing Guided Triple Therapy Versus 14-Day Empirical Tailored Therapy for the First-line Treatment of Helicobacter Pylori Infection-A Randomized Controlled Trail |
Unknown status |
NCT03571230 |
Phase 4 |
two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone and tetracycline);two antibiotics based on personal medication history(amoxicillin,clarithromycin,furazolidone);one proton pump inhibitor(PPI);Colloidal Bismuth Pectin;two antibiotics for failed eradication(tetracyclin,furazolidone) |
10 |
Double-blind, Placebo-controlled, Randomized Study for Assesment of the Efficiency and Safety Quadruple Therapy for Helicobacter Pylori Infection With or Without the Addition of Saccharomyces Boulardi Probiotic |
Unknown status |
NCT03997279 |
Phase 4 |
Saccharomyces boulardii;Placebo |
11 |
Comparison of the Efficacy of Sequential Therapy and Bismuth Quadruple Therapy in the First Line and Second Line Therapy for Helicobacter Pylori Infection- A Multi-center Randomized Trial |
Unknown status |
NCT03156855 |
Phase 4 |
14-day sequential therapy;Bismuth quadruple therapy |
12 |
A Randomized, Double-blind, Placebo-controlled Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice |
Unknown status |
NCT03150394 |
Phase 4 |
|
13 |
Comparison of Triple Therapy Regimens Effectiveness Over 10 Days and 14 Days in Eradication of Helicobacter Pylori Infection: Double Blind Randomized Clinical Trial |
Unknown status |
NCT03134378 |
Phase 4 |
Rabeprazole Sodium 20mg;Clarithromycin 500mg;Amoxicillin 500 Mg |
14 |
Efficacy and Safety of a 14-day Modified Sequential Therapy for Refractory Helicobacter Pylori Infection: an Open Randomized Pilot Study |
Unknown status |
NCT03658733 |
Phase 4 |
esomeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days);rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) |
15 |
Efficacy and Safety of a 14-day Modified Sequential Therapy for Refractory Helicobacter Pylori Infection: a Pilot Study |
Unknown status |
NCT03616405 |
Phase 4 |
rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) |
16 |
Intravenous Administration of Metronidazole, Levofloxacin and Esomeprazole Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease |
Unknown status |
NCT04432233 |
Phase 4 |
Esomeprazole;Metronidazole;Levofloxacin |
17 |
Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection- A Multi-center Randomized Trial |
Unknown status |
NCT01537055 |
Phase 4 |
levofloxacin-based sequential therapy;levofloxacin-based triple therapy for 10 days |
18 |
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection |
Unknown status |
NCT02934048 |
Phase 4 |
|
19 |
Genotypic Resistance Guided Therapy in the Treatment of Helicobacter Pylori Infection |
Unknown status |
NCT01725906 |
Phase 4 |
empirical therapy;Genotypic resistance guided therapy |
20 |
Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy as Rescue Treatment for Helicobacter Pylori Infection After Failure of Several Therapy |
Unknown status |
NCT02894268 |
Phase 4 |
Doxycycline;Furazolidone;Esomeprazole;Colloidal Bismuth Subcitrate;Sensitivity antibiotics |
21 |
A Prospective Open-label Study on Efficacy and Tolerability of Colloidal Bismuth Sub-citrate as Adjunctive Therapy to a Combination of Esomeprazole, Amoxicillin and Metronidazole for 10 Days for Helicobacter Pylori Elimination in Children |
Unknown status |
NCT03299725 |
Phase 4 |
colloidal bismuth sub-citrate |
22 |
Tailored Therapy Versus Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Randomized Trial |
Unknown status |
NCT02635191 |
Phase 4 |
Tailored Group;Standard group |
23 |
A Randomized Controlled Trial of Triple Therapy With Conventional Proton Pump Inhibitor vs Triple Therapy With Vonoprazan as First Line Therapy for Helicobacter Pylori Gastritis |
Unknown status |
NCT03908619 |
Phase 4 |
Omeprazole 20mg;Esomeprazole 20mg;Rabeprazole Sodium 20mg;Vonoprazan |
24 |
Genotypic Resistance-guided Triple Therapy Versus Empirical Concomitant Therapy for First-line H. Pylori Eradication. |
Unknown status |
NCT04090021 |
Phase 4 |
Esomeprazole 40mg;Clarithromycin 500mg;Metronidazole 500 mg;Amoxicillin 1000 MG;Levofloxacin 500mg;Rifabutin 150 MG |
25 |
Bismuth-Metronidazole Triple Versus Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Randomized Controlled Trial |
Unknown status |
NCT04667299 |
Phase 4 |
Rabeprazole;Bismuth potassium citrate;Metronidazole;Amoxicillin |
26 |
Helicobacter Pylori Eradication According to DPO-PCR Methods: Duration of Triple Therapy and Bismuth Quadruple According to Clarithromycin Resistance Patterns |
Unknown status |
NCT04147065 |
Phase 4 |
Duration of eradication regimen |
27 |
The Efficacy of Probiotic Supplementation in the Reduction of Adverse Effects and Dysbiosis of Helicobacter Pylori Eradication Therapy - A Double Blind, Multi-center Randomized, Placebo Controlled Trial |
Unknown status |
NCT03722433 |
Phase 4 |
Vigiis 101-LAB and sequential therapy;Placebo and sequential therapy |
28 |
Efficacy of Two Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment |
Unknown status |
NCT02988089 |
Phase 4 |
Clarithromycin susceptibility dependant strategy;2 susceptible antibiotics (amoxicillin, clarithromycin, metronidazole, tinidazole,levofloxacin, furazolidone and tetracycline );proton pump inhibitor (PPI) and Colloidal Bismuth Pectin;amoxicillin and clarithromycin or amoxicillin and furazolidone;amoxicillin and furazolidone or amoxicillin and tetracycline;amoxicillin and furazolidone or amoxicillin and Tinidazole or amoxicillin and Levofloxacin |
29 |
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori: A Pilot Study |
Unknown status |
NCT03726099 |
Phase 4 |
esomeprazole, amoxicillin, furazolidone,tetracycline |
30 |
The Effect of Broccoli Sprout Extract and Probiotics on Proton Pump Inhibitor-based Triple Therapy for Eradication of Helicobacter Pylori: a Prospective Randomized Trial |
Unknown status |
NCT03220542 |
Phase 4 |
Probiotics;Esomeprazole;Amoxicillin;Clarithromycin |
31 |
Comparison of Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori- a Multicenter Randomized Trial |
Unknown status |
NCT03556254 |
Phase 4 |
GGT;SGT |
32 |
Community-based Helicobacter Pylori Eradication With Two Sequential Antibiotic Regimens for the Residents and Migrants From a High-risk Area for Gastric Cancer |
Unknown status |
NCT00155389 |
Phase 4 |
Helicobacter pylori eradication |
33 |
Helicobacter Pylori Eradication Rates of Concomitant Therapy and Tailored Therapy Based on 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance: A Multicenter Prospective Randomized Study |
Unknown status |
NCT03130452 |
Phase 4 |
Lansoprazole 30mg;Amoxicillin 1.0g Tab;Clarithromycin 500mg;Metronidazole 500 mg |
34 |
Phase 4 Study of Helicobacter Pylori Eradication Therapy |
Unknown status |
NCT00990405 |
Phase 4 |
Lansoprzole+Amoxicillin+Clarithromycin |
35 |
Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy |
Unknown status |
NCT01265069 |
Phase 4 |
high dose dual therapy;concomitant therapy |
36 |
Phase 4, Prospective, Randomized Study Comparing 14-day Non-bismuth Quadruple "Hybrid" and "Concomitant" Therapies for Helicobacter Pylori Eradication in Settings With High Clarithromycin Resistance |
Unknown status |
NCT01464060 |
Phase 4 |
PPI, amoxicillin, metronidazole and clarithromycin |
37 |
Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections |
Unknown status |
NCT01566643 |
Phase 4 |
RA5-RACM7;RA3-RACM7;RA7-RACM7 |
38 |
Does Eradication of H-pylori in Pregnant Patients With Iron Deficiency Anemia Have an Effect on Iron Replacement Therapy? |
Unknown status |
NCT03347513 |
Phase 4 |
triple attack therapy;Ferrous(II)-glycine-sulphate complex 567.7 mg capsules |
39 |
Comparison of Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the Third-line Eradication of H. Pylori- a Multicenter Randomized Trial |
Unknown status |
NCT03555526 |
Phase 4 |
Esomeprazole 40mg;Amoxicillin;metronidazole;Levofloxacin 500mg;Clarithromycin ER;Dibismuth trioxide;tetracycline |
40 |
Helicobacter Pylori Eradication Using a Bismuth Quadruple Therapy Among Asymptomatically Infected Adults in El Paso, Texas: A Pilot Study. |
Unknown status |
NCT01335334 |
Phase 4 |
bismuth subcitrate potassium, metronidazole,tetracycline hydrochloride and omeprazole |
41 |
Prospective Randomized Trial: Comparison Between Optimized-dose Amoxicillin and Standard-dose Amoxicillin for Quadruple Therapy in the Treatment of Helicobacter Pylori Infection in Tunisian Patients |
Completed |
NCT05635942 |
Phase 4 |
optimized quadruple therapy;standard quadruple therapy |
42 |
Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection - A Combination of Clinical and Pharmacogenetic Study |
Completed |
NCT00854451 |
Phase 4 |
omeprazole plus amoxicillin |
43 |
Sequential Versus Concomitant Therapy for Helicobacter Pylori Infection |
Completed |
NCT00656968 |
Phase 4 |
10-day sequential treatment;10-day concomitant therapy |
44 |
A Double Blind Randomized Study for Treatment of Helicobacter Pylori Infection: 14-day Non-bismuth Quadruple Therapy Versus Triple Therapy. |
Completed |
NCT04769583 |
Phase 4 |
metronidazole based quadriple therapy;placebo based quadriple therapy |
45 |
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection |
Completed |
NCT02711176 |
Phase 4 |
Nexium;Tinafas;Tavanex;Lanzol;Klacid;Iramox |
46 |
Randomized Clinical Trial: the Comparison of 15-day Sequential and 10-day Sequential Therapy to PPI-based Triple Therapy for Helicobacter Pylori Infection in Korea |
Completed |
NCT01887249 |
Phase 4 |
Clarithromycin;metronidazole;esomeprazole |
47 |
Effect of Saccaromyces Boulardii CNCM I-745 Supplementation on the Fecal Resistome of Patients Treated Against Helicobacter Pylori Infection |
Completed |
NCT04786938 |
Phase 4 |
Saccharomyces Boulardii-Containing Product in Oral Dose Form |
48 |
A Randomized Controlled Trial of Triple Therapy Versus Sequential Therapy Versus Concomitant Therapy as First Line Treatment for Helicobacter Pylori Infection |
Completed |
NCT02092506 |
Phase 4 |
10 day triple therapy;10 day sequential therapy;10 day concomitant therapy |
49 |
Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura |
Completed |
NCT00467571 |
Phase 4 |
lansoprazole, clarithromycin, amoxycillin |
50 |
Intraluminal Therapy for Helicobacter Pylori Infection |
Completed |
NCT03124420 |
Phase 4 |
Lansoprazole;Amoxicillin;Clarithromycin |
|